... extended EFS for patients with early triple-negative breast cancer, according to results presented at San Antonio Breast Cancer Symposium.
News
- Data further support pembrolizumab regimen for early triple-negative breast cancer - Healio
- Here is why BriaCell Therapeutics Corp. (BCTX) recent weekly performance of - Invest Chronicle
... Data Poster Presented at the 2021 San Antonio Breast Cancer Symposium®. ... a clinical-stage biotechnology company specializing in targeted ...
- Context Therapeutics gains ahead of clinical data for breast cancer candidate - Seeking Alpha
... the presentations will be conducted at the 2021 San Antonio Breast ... Context Therapeutics: A New Biotech Issue With A Low Valuation And ...
- Texas Biomed facility to address research-threatening primate shortage | kens5.com
SAN ANTONIO — Texas Biomedical Research Institute leaders Wednesday broke ground on a state-of-the-art animal care center that will help address ...
- Spurs knock off Nuggets despite Nikola Jokic's third-straight triple-double - The Denver Post
Denver Nuggets' Aaron Gordon (50) drives against San Antonio Spurs' ... beats out California, Massachusetts for new site of bioscience company ...